Healthcare -
Biotechnology - NASDAQ - US
$ 0.023
-0.87 %
$ 914 K
Market Cap
-0.02
P/E
VIRX - FREE CASH FLOW
Free Cash Flow VIRX - Viracta Therapeutics, Inc.
-40 M
LAST VALUE
-31.63%
2 YEAR CAGR
-10.40%
5 YEAR CAGR
-0.68%
10 YEAR CAGR